Arthur F. Ryan - 01 Nov 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Arthur F. Ryan
Issuer symbol
REGN
Transactions as of
01 Nov 2021
Net transactions value
-$64,252
Form type
4
Filing time
03 Nov 2021, 16:11:40 UTC
Previous filing
04 Oct 2021
Next filing
02 Dec 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale $3,832 -6 -0.03% $638.62 23,185 01 Nov 2021 Direct F1, F2
transaction REGN Common Stock Sale $7,035 -11 -0.05% $639.52 23,174 01 Nov 2021 Direct F1, F3
transaction REGN Common Stock Sale $10,881 -17 -0.07% $640.08 23,157 01 Nov 2021 Direct F1, F4
transaction REGN Common Stock Sale $12,189 -19 -0.08% $641.52 23,138 01 Nov 2021 Direct F1, F5
transaction REGN Common Stock Sale $5,781 -9 -0.04% $642.28 23,129 01 Nov 2021 Direct F1, F6
transaction REGN Common Stock Sale $644 -1 -0% $643.82 23,128 01 Nov 2021 Direct F1
transaction REGN Common Stock Sale $5,802 -9 -0.04% $644.62 23,119 01 Nov 2021 Direct F1, F7
transaction REGN Common Stock Sale $9,681 -15 -0.06% $645.41 23,104 01 Nov 2021 Direct F1, F8
transaction REGN Common Stock Sale $3,232 -5 -0.02% $646.37 23,099 01 Nov 2021 Direct F1, F9
transaction REGN Common Stock Sale $5,176 -8 -0.03% $647.00 23,091 01 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 6 shares of Company stock on November 1, 2021 at prices ranging from $638.57 to $638.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price.
F3 Represents volume-weighted average price of sales of 11 shares of Company stock on November 1, 2021 at prices ranging from $639.17 to $639.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price.
F4 Represents volume-weighted average price of sales of 17 shares of Company stock on November 1, 2021 at prices ranging from $640.00 to $640.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price.
F5 Represents volume-weighted average price of sales of 19 shares of Company stock on November 1, 2021 at prices ranging from $641.11 to $641.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price.
F6 Represents volume-weighted average price of sales of 9 shares of Company stock on November 1, 2021 at prices ranging from $642.00 to $642.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price.
F7 Represents volume-weighted average price of sales of 9 shares of Company stock on November 1, 2021 at prices ranging from $644.21 to $644.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price.
F8 Represents volume-weighted average price of sales of 15 shares of Company stock on November 1, 2021 at prices ranging from $645.01 to $645.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price.
F9 Represents volume-weighted average price of sales of 5 shares of Company stock on November 1, 2021 at prices ranging from $646.00 to $646.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price.